Frontlight ResearchEarly access
Taking peopleNo phase
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
Key facts
- Who runs it
- Merit Medical Systems, Inc.
- Where
- Brooklyn, United StatesSee the siteAlso in 2 other countries, 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 22 Aug 2024
- Expected to end
- Jun 2027
- Type of study
- Observational
- Treatments tested
- Bearing nsPVA
- Record updated
- 7 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adult women ≥ 18 years old at the time of enrollment
- Subject has symptomatic uterine fibroid(s), suitable to embolization
- Subject provides written informed consent
Who cannot take part
- Subject has suspected pelvic inflammatory disease or any other pelvic infection
- Subject has any malignancy of the pelvic region, (e.g., endometrial neoplasia)
- Subject is pregnant
Where in United States
Also in 2 other countries, 3 sites
- Astra Vascular/Astra Vein Treatment CenterBrooklyn, United StatesContact: Molly RyanNo longer taking part
About the trial
What the trial wants to find out
This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.
Treatments tested
- Bearing nsPVA
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective, Multi-Center Study Using Bearing nsPVA Embolization Particles for the Treatment of uTErine fibRoids With Uterine Artery Embolization
- Record updated
- 7 October 2026